- জেনেরিক নাম
- Rivaroxaban
- শক্তি
- 10 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- The ACME Laboratories Ltd.
RIVARA 10 Tablet
RIVARA 10 Tablet সম্পর্কে
RIVARA 10 হলো Rivaroxaban-এর একটি ব্র্যান্ড, শক্তি ১০ mg, ট্যাবলেট আকারে। এটি তৈরি করে The ACME Laboratories Ltd। Rivaroxaban-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Rivaroxaban-এর ১৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Rivadel 2.5 Tablet-এর, প্রতি ইউনিট ৳ ৫।
RIVARA 10 Tablet কী?
RIVARA 10 comes as a tablet with 10 mg of Rivaroxaban, from The ACME Laboratories Ltd. Rivaroxaban works by blocking factor Xa, a substance in the blood clotting process, which reduces the formation of thrombin and helps make clots less likely. Its active ingredient is Rivaroxaban, supplied in a 10 mg strength. Use it only as your doctor directs.
RIVARA 10-এর ব্যবহার
It is an oral anticoagulant, sometimes called a blood thinner. RIVARA 10 is used in adults to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, and in the treatment of deep vein thrombosis and pulmonary embolism. RIVARA 10 is used to reduce the risk of stroke and systemic embolism in people with nonvalvular atrial fibrillation, a type of irregular heartbeat. Whether it suits a particular person depends on their condition and medical history, so the doctor decides if it is appropriate.
RIVARA 10 কীভাবে ব্যবহার করবেন
Some Rivaroxaban products are taken with food or with the evening meal, so follow the instructions given to you. Swallow the tablet with water. RIVARA 10 is taken by mouth. Take RIVARA 10 tablet exactly as your doctor tells you. Do not stop taking it without medical advice, since stopping suddenly can raise the risk of clots. If you miss a dose or are unsure about anything, ask your doctor or pharmacist rather than adjusting it on your own.
RIVARA 10-এর পার্শ্বপ্রতিক্রিয়া
In people with nonvalvular atrial fibrillation, stopping the medicine raises the risk of stroke. This can include nosebleeds, gum bleeding, easy bruising, or longer bleeding from small cuts. The most common side effect of Rivaroxaban is a greater chance of bleeding, which may appear as bruising, nosebleeds or bleeding gums, or bleeding that is hard to stop. Contact your doctor if you notice anything unusual after taking it. Tell your doctor promptly about any unusual or prolonged bleeding.
সতর্কতা ও নিরাপত্তা
It is a pregnancy category C drug; safety in pregnancy and breastfeeding has not been established, so ask your doctor first. It must not be used by people allergic to Rivaroxaban or any ingredient of the tablet, or by people with active pathological bleeding. Do not start or stop it without your doctor's guidance. Tell your doctor before starting RIVARA 10 if you have a bleeding disorder, uncontrolled severe high blood pressure, stomach or bowel disease, vascular retinopathy, bronchiectasis or a history of lung bleeding, as these can raise the risk of serious bleeding.
সাধারণ প্রশ্ন
What does RIVARA 10 treat?
It is an oral anticoagulant, sometimes called a blood thinner. RIVARA 10 is used in adults to lower the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, and in the treatment of deep vein thrombosis and pulmonary embolism.
How do I use RIVARA 10 correctly?
Some Rivaroxaban products are taken with food or with the evening meal, so follow the instructions given to you. Swallow the tablet with water.
What are the side effects of RIVARA 10?
In people with nonvalvular atrial fibrillation, stopping the medicine raises the risk of stroke. This can include nosebleeds, gum bleeding, easy bruising, or longer bleeding from small cuts.
Can I use RIVARA 10 in pregnancy or while breastfeeding?
It is a pregnancy category C drug; safety in pregnancy and breastfeeding has not been established, so ask your doctor first. It must not be used by people allergic to Rivaroxaban or any ingredient of the tablet, or by people with active pathological bleeding.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:- For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
- For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.
- To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
- Deep vein thrombosis (DVT) & pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE
- For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:- The recommended dose: 2.5 mg twice daily. Patients should also take a daily dose of 75-100 mg Aspirin or a daily dose of 75-100 mg Aspirin in addition to either a daily dose of 75 mg clopidogrel or a standard daily dose of ticlopidine.
- Nonvalvular Atrial Fibrillation: For patients with Creatinin Clearance >50 mL/min: 20 mg orally, once daily with the evening meal. For patients with Creatinin Clearance 15-50 ml/min: 15 mg orally, once daily with the evening meal.
- Treatment of DVT & PE: 15 mg orally twice daily with food for the first 21 days for the initial treatment of acute DVT or PE. After the initial treatment period, 20 mg orally once daily with food for the remaining treatment.
- Prevention in the risk of recurrence of DVT and of PE: 20 mg once daily with food.
- Prophylaxis of DVT following Hip replacement surgery: 10 mg once daily for 35 days.
- Prophylaxis of DVT following knee replacement surgery: 10 mg once daily for 12 days.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.বিকল্প ব্র্যান্ড: Rivaroxaban
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।